会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明授权
    • Method and apparatus for visible light communication with image processing
    • 用于与图像处理可见光通信的方法和装置
    • US08538276B2
    • 2013-09-17
    • US12855542
    • 2010-08-12
    • Shigehito ShimadaHideki UenoMinoru FujitaAtsushi Kataoka
    • Shigehito ShimadaHideki UenoMinoru FujitaAtsushi Kataoka
    • H04B10/06
    • H04B10/116H04B10/1141
    • According to one embodiment, a visible-light communication apparatus includes an image input unit, a calculation unit, a preamble detection unit, a bit train detection unit, and a reception unit. The image input unit is configured to input image data generated by photographing a source of visible light carrying data. The calculation unit is configured to generate, from the image data, luminance data about an image at a designated position. The preamble detection unit is configured to detect a preamble at the head of the data, on the basis of the luminance data. The bit train detection unit is configured to detect the data bit train from the image data, in accordance with the preamble. The reception unit is configured to reproduce the data from the data bit train.
    • 根据一个实施例,可见光通信装置包括图像输入单元,计算单元,前导码检测单元,位列检测单元和接收单元。 图像输入单元被配置为输入通过拍摄可见光携带数据的源产生的图像数据。 计算单元被配置为从图像数据生成关于指定位置处的图像的亮度数据。 前导码检测单元被配置为基于亮度数据检测数据的头部的前导码。 比特列表检测单元被配置为根据前导码从图像数据检测数据比特串。 接收单元被配置为从数据位列再现数据。
    • 3. 发明授权
    • Method for production of antimutagenic substance using lactic acid bacterium
    • 使用乳酸菌生产抗诱变物质的方法
    • US08440426B2
    • 2013-05-14
    • US12450817
    • 2008-04-18
    • Minoru FujitaMasaharu NakayamaYasuteru NakamuraTakahiro Inoue
    • Minoru FujitaMasaharu NakayamaYasuteru NakamuraTakahiro Inoue
    • C12P1/00
    • C12P1/04A61K35/747C12R1/225C12R1/25
    • Disclosed is a method for producing an antimutagenic substance by using a lactic acid bacteria, which can produce the antimutagenic substance in a large quantity in an extremely simple manner and is economically advantageous; particularly a method for producing an antimutagenic substance effective for a carcinogenic substance, particularly a heterocyclic amine (HCA) which is a carcinogenic substance derived from a food, by using a lactic acid bacteria. Specifically disclosed is a method for producing an antimutagenic substance by using a lactic acid bacteria, which is characterized by suspending the lactic acid bacteria in a poorly nutrient or nutrient-free medium and leaving the lactic acid bacteria in the medium. Preferably, the poorly nutrient or nutrient-free medium is selected from the group consisting of physiological saline, a phosphate-buffered saline without a calcium or magnesium salt (PBS (−)), a citrate buffer, a distilled water, an ion-exchanged water, a natural water, a well water, a tap water, a mineral-added water, a vitamin-added water, an ion supply beverage for an athlete and the like. More preferably, the lactic acid bacteria is Lactobacillus plantarum strain KK-2503 or Lactobacillus alimentarius strain KN-15.
    • 本发明公开了一种通过使用能以非常简单的方式大量生产抗诱变物质的乳酸菌生产抗诱变物质的方法,在经济上是有利的; 特别是通过使用乳酸菌,制造对致癌物质,特别是作为来源于食品的致癌物质的杂环胺(HCA)有效的抗诱变物质的方法。 具体公开了通过使用乳酸菌制造抗诱变物质的方法,其特征在于将乳酸菌悬浮在营养不良或营养不良的培养基中,并将乳酸菌留在培养基中。 优选地,营养不良或营养不良的培养基选自生理盐水,不含钙或镁盐的磷酸盐缓冲盐水(PBS( - )),柠檬酸盐缓冲液,蒸馏水,离子交换 水,天然水,井水,自来水,矿物质添加水,维生素添加水,运动员的离子供应饮料等。 更优选地,乳酸菌是植物乳杆菌菌株KK-2503或者Lactobacillus alimentarius菌株KN-15。
    • 6. 发明申请
    • METHOD FOR PRODUCTION OF ANTIMUTAGENIC SUBSTANCE USING LACTIC ACID BACTERIUM
    • 使用乳酸菌生产抗生素的方法
    • US20100143965A1
    • 2010-06-10
    • US12450817
    • 2008-04-18
    • Minoru FujitaMasaharu NakayamaYasuteru NakamuraTakahiro Inoue
    • Minoru FujitaMasaharu NakayamaYasuteru NakamuraTakahiro Inoue
    • C12P1/00
    • C12P1/04A61K35/747C12R1/225C12R1/25
    • Disclosed is a method for producing an antimutagenic substance by using a lactic acid bacterium, which can produce the antimutagenic substance in a large quantity in an extremely simple manner and is economically advantageous; particularly a method for producing an antimutagenic substance effective for a carcinogenic substance, particularly a heterocyclic amine (HCA) which is a carcinogenic substance derived from a food, by using a lactic acid bacterium. Specifically disclosed is a method for producing an antimutagenic substance by using a lactic acid bacterium, which is characterized by suspending the lactic acid bacterium in a poorly nutrient or nutrient-free medium and leaving the lactic acid bacterium in the medium. Preferably, the poorly nutrient or nutrient-free medium is selected from the group consisting of physiological saline, a phosphate-buffered saline without a calcium or magnesium salt (PBS (−)), a citrate buffer, a distilled water, an ion-exchanged water, a natural water, a well water, a tap water, a mineral-added water, a vitamin-added water, an ion supply beverage for an athlete and the like. More preferably, the lactic acid bacterium is Lactobacillus plantarum strain KK-2503 or Lactobacillus alimentarius strain KN-15.
    • 本发明公开了一种通过使用乳酸菌制造抗诱变物质的方法,其能够以非常简单的方式大量生产抗诱变物质,在经济上是有利的; 特别是通过使用乳酸菌,制造对致癌物质,特别是作为来自食品的致癌物质的杂环胺(HCA)有效的抗诱变物质的方法。 具体公开了通过使用乳酸菌制造抗诱变物质的方法,其特征在于将乳酸菌悬浮于营养不良或营养不良的培养基中,并将乳酸菌留在培养基中。 优选地,营养不良或营养不良的培养基选自生理盐水,不含钙或镁盐的磷酸盐缓冲盐水(PBS( - )),柠檬酸盐缓冲液,蒸馏水,离子交换 水,天然水,井水,自来水,矿物质添加水,维生素添加水,运动员的离子供应饮料等。 更优选地,乳酸菌是植物乳杆菌菌株KK-2503或者乳酸乳杆菌菌株KN-15。
    • 10. 发明授权
    • Reagent for an immunoassay
    • 免疫测定试剂
    • US07279339B2
    • 2007-10-09
    • US10867912
    • 2004-06-15
    • Kyoichi SumidaMinoru FujitaHiromichi Adachi
    • Kyoichi SumidaMinoru FujitaHiromichi Adachi
    • G01N33/543
    • G01N33/54313
    • The present invention relates to (1) A reagent for an immunoassay of a target substance existing in a free form and a bound form in a specimen, comprising a latex 1 which is immobilized with a monoclonal antibody 1 for the target substance, and a latex 2 which has a different mean particle size from the latex 1 and is immobilized with a monoclonal antibody 2 having a different recognition site for the target substance from the antibody 1, (2) An immunoassay method comprising reacting the target substance with the reagent of (1) and determining an amount of the substance based on the result of an agglutination reaction among the target substance, the latex1 and the latex2, and (3) A reagent kit comprising a reagent of (1) and a reagent containing an agglutination accelerator for an antigen-antibody reaction.
    • 本发明涉及(1)一种试样中游离形式和结合形式存在的目标物质的免疫测定试剂,其特征在于,包含用目标物质单克隆抗体1固定的胶乳1和胶乳 2,其具有与胶乳1不同的平均粒度,并且用来自抗体1的靶物质具有不同识别位点的单克隆抗体2固定化。(2)一种免疫测定方法,包括使目标物质与( 1),并且基于目标物质,胶乳1和胶乳2之间的凝集反应结果确定物质的量,和(3)包含试剂(1)的试剂盒和含有凝集促进剂的试剂 抗原 - 抗体反应。